1. Home
  2. LOB vs VCEL Comparison

LOB vs VCEL Comparison

Compare LOB & VCEL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Live Oak Bancshares Inc.

LOB

Live Oak Bancshares Inc.

HOLD

Current Price

$38.84

Market Cap

1.9B

Sector

Finance

ML Signal

HOLD

Logo Vericel Corporation

VCEL

Vericel Corporation

HOLD

Current Price

$37.33

Market Cap

2.0B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
LOB
VCEL
Founded
2008
1989
Country
United States
United States
Employees
N/A
N/A
Industry
Major Banks
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.9B
2.0B
IPO Year
2014
1996

Fundamental Metrics

Financial Performance
Metric
LOB
VCEL
Price
$38.84
$37.33
Analyst Decision
Buy
Strong Buy
Analyst Count
4
5
Target Price
$42.75
$57.50
AVG Volume (30 Days)
305.2K
386.6K
Earning Date
04-22-2026
04-03-2026
Dividend Yield
0.31%
N/A
EPS Growth
3.05
385.71
EPS
1.28
N/A
Revenue
N/A
$237,224,000.00
Revenue This Year
$35.52
$18.02
Revenue Next Year
$16.03
$18.52
P/E Ratio
$30.19
N/A
Revenue Growth
N/A
20.10
52 Week Low
$22.68
$29.24
52 Week High
$42.89
$55.41

Technical Indicators

Market Signals
Indicator
LOB
VCEL
Relative Strength Index (RSI) 48.55 51.72
Support Level $34.63 $34.61
Resistance Level $39.16 $38.41
Average True Range (ATR) 1.50 1.65
MACD -0.41 0.28
Stochastic Oscillator 36.11 74.26

Price Performance

Historical Comparison
LOB
VCEL

About LOB Live Oak Bancshares Inc.

Live Oak Bancshares Inc operates as the bank holding company for the Live Oak Banking Company. The company specializes in lending and deposit-related services to small businesses nationwide. The company identifies and extends lending to credit-worthy borrowers both within specific industries, also called verticals, through expertise within those industries, and more broadly to select borrowers outside of those industries. A portion of the loans originated by the Bank are partially guaranteed by the Small Business Administration under the 7(a) Loan Program and the U.S. Department of Agriculture Rural Energy for America Program, Water and Environmental Program, Business and Industry and Community Facilities loan programs.

About VCEL Vericel Corporation

Vericel Corp is a fully integrated, commercial-stage biopharmaceutical company and a provider of therapies for the sports medicine and severe burn care markets. It markets cell therapy products in the United States, MACI (autologous cultured chondrocytes on porcine collagen membrane); Epicel (cultured epidermal autografts); and NexoBrid. The Company operates its business in the U.S. in one reportable segment; the research, product development, manufacture, and distribution of cellular therapies and specialty biologics for use in the treatment of specific conditions.

Share on Social Networks: